Chiao-hsuan Chao
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
SARS-CoV-2 Spike Protein-Mediated Cardiac Dysfunction: Structural Abnormalities, Impaired Calcium Dynamics, and Gene Expression Changes in Human Stem Cell-Derived Cardiomyocytes.
Journal: Journal of medical virology
Published: August 08, 2025
A non-structural protein 1 substitution of dengue virus enhances viral replication by interfering with the antiviral signaling pathway.
Journal: Journal of biomedical science
Published: September 15, 2024
Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need.
Journal: Microbiology spectrum
Published: May 15, 2024
Cellular and humoral immunity following two AZD1222 and two booster vaccinations in hemodialysis patients.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: February 18, 2024
VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71.
Journal: Journal of virology
Published: January 04, 2024
Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19.
Journal: Journal of biomedical science
Published: December 07, 2023
Trajectory of Humoral Responses to Two Doses of ChAdOx1 nCoV-19 Vaccination in Patients Receiving Maintenance Hemodialysis.
Journal: Microbiology spectrum
Published: February 22, 2023
Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan.
Journal: Frontiers in immunology
Published: August 20, 2022
Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis.
Journal: Frontiers in immunology
Published: May 12, 2022
Impact of Intrahost NS5 Nucleotide Variations on Dengue Virus Replication.
Journal: Frontiers in microbiology
Published: March 11, 2022
Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2.
Journal: Frontiers in immunology
Published: February 03, 2022
A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.
Journal: Vaccine
Published: September 02, 2021
Last Updated: 09/26/2026